INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 48 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|